Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,787 | -10,699 | 11,862 | 18,094 | 7,752 |
| Depreciation Amortization | 13,252 | 14,448 | 13,078 | 11,497 | 11,150 |
| Income taxes - deferred | -7,880 | -8,743 | 2,248 | 11,583 | -29,680 |
| Accounts receivable | -11,012 | 1,210 | 11,824 | -16,647 | -1,171 |
| Other Working Capital | -5,028 | 15,619 | -3,231 | -49,646 | 27,579 |
| Other Operating Activity | 24,136 | 9,217 | -4,739 | 23,469 | 3,466 |
| Operating Cash Flow | $10,681 | $21,052 | $31,042 | $-1,650 | $19,096 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 513 | 810 | 185 |
| PPE Investments | -15,996 | -20,499 | -18,302 | -23,662 | -10,676 |
| Net Acquisitions | N/A | -18,352 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,509 | -42 |
| Other Investing Activity | -929 | -922 | -509 | -2,260 | -44 |
| Investing Cash Flow | $-16,925 | $-39,773 | $-18,298 | $-25,112 | $-10,535 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,785 | 51,505 | 66,000 | 53,961 | N/A |
| Debt Repayment | -8,991 | -48,216 | -73,152 | -30,126 | -5,900 |
| Common Stock Issued | 14,308 | 38,200 | 55 | 333 | 58 |
| Common Stock Repurchased | -9,865 | -345 | -199 | -811 | -1,754 |
| Other Financing Activity | 0 | -9,027 | -2,074 | -120 | -980 |
| Financing Cash Flow | $2,237 | $32,117 | $-9,370 | $23,237 | $-8,576 |
| Exchange Rate Effect | 2,253 | 845 | N/A | 0 | N/A |
| Beginning Cash Position | 67,828 | 53,587 | 50,213 | 53,738 | 53,753 |
| End Cash Position | 66,074 | 67,828 | 53,587 | 50,213 | 53,738 |
| Net Cash Flow | $-1,754 | $14,241 | $3,374 | $-3,525 | $-15 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,681 | 21,052 | 31,042 | -1,650 | 19,096 |
| Capital Expenditure | -15,996 | -20,499 | -18,302 | -23,736 | -10,676 |
| Free Cash Flow | -5,315 | 553 | 12,740 | -25,386 | 8,420 |